Investor Relations Corporate Profile Evolus is a medical aesthetics company focused on providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. FINANCIAL NEWS April 24, 2019 Evolus to Release First Quarter 2019 Financial Results and Provide a Business Update on Tuesday, April 30, 2019 April 8, 2019 Evolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveau™ and BOTOX® in Aesthetic Surgery Journal April 1, 2019 Evolus Provides Regulatory Update on Nuceiva™ in the European Union View all EVENTS Evolus Investor & Analyst Day May 8, 2019 at 9:00 AM EDT Q1 2019 Evolus Earnings Conference Call Apr 30, 2019 at 4:30 PM EDT Q4 and Full Year 2018 Evolus Earnings Conference Call Mar 18, 2019 at 4:30 PM EDT View all PRESENTATION Call to Discuss Head-to-Head Pivotal Trial Results Presentation Apr 08, 2019 Aesthetic Surgery Journal Apr 08, 2019 Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies Mar 21, 2019
April 24, 2019 Evolus to Release First Quarter 2019 Financial Results and Provide a Business Update on Tuesday, April 30, 2019
April 8, 2019 Evolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveau™ and BOTOX® in Aesthetic Surgery Journal
Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies Mar 21, 2019
